Efficacy safety of linaclotide combined with polyethylene glycol for bowel preparation in patients with constipation: a meta-analysis
Frontiers in Gastroenterology · 14.07.2026 · 5
DOI: 10.3389/fgstr.2026.1694950 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Gastroenterology, online erschienen am 14.07.2026. Verfasst von Guoli Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Qinghai University Affiliated Hospital, Xining, Qinghai, China. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
In patients with chronic constipation, standard bowel preparation using polyethylene glycol (PEG) often results in inadequate intestinal cleansing, complicating colonoscopy. This study systematically assessed the efficacy and safety of linaclotide combined with PEG (linaclotide-PEG) compared to PEG alone.
Methods
A systematic search was conducted in PubMed, EMBASE, Web of Science, CENTRAL, CNKI, VIP, and Wanfang databases up to February 1, 2025, to identify randomized controlled trials (RCTs) comparing linaclotide-PEG with PEG monotherapy in constipated patients. Study quality was assessed using the Cochrane Risk of Bias (RoB 2) tool. Data analyses were performed using Stata 16.0.
Results
Eleven RCTs (2022-2024) involving 1,525 participants were included. Compared to PEG alone, linaclotide-PEG significantly improved overall bowel preparation quality [mean difference (MD)=0.82; 95% confidence interval (CI): 0.58-1.05; P < 0.05] and segment-specific cleansing scores (left colon: MD = 0.28; right colon: MD = 0.34; transverse colon: MD = 0.35; all P < 0.05). Additionally, polyp detection rate increased, procedural duration and cecal intubation times decreased, and patients’ willingness to repeat colonoscopy improved significantly (all P < 0.05). The linaclotide-PEG regimen also reduced adverse reaction (nausea and vomiting events) (P < 0.05). No significant publication bias was detected (Egger’s and Begg’s tests: P > 0.05).
Conclusion
Linaclotide-PEG is superior to PEG alone, enhancing bowel cleansing effectiveness, increasing lesion detection rates, shortening procedure times, and reducing adverse events, thus offering clear clinical advantages. Systematic review registration https://www.crd.york.ac.uk/PROSPERO/ , identifier CRD420250652929.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Qinghai University Affiliated Hospital, Xining, Qinghai, China.
Zitieren
APA
Li, G., Zhang, H., Li, L., & Huang, Y. (2026). Efficacy safety of linaclotide combined with polyethylene glycol for bowel preparation in patients with constipation: a meta-analysis. Frontiers in Gastroenterology, 5. https://doi.org/10.3389/fgstr.2026.1694950
Vancouver
Li G, Zhang H, Li L, Huang Y. Efficacy safety of linaclotide combined with polyethylene glycol for bowel preparation in patients with constipation: a meta-analysis. Frontiers in Gastroenterology. 2026;5. doi:10.3389/fgstr.2026.1694950
BibTeX
@article{Li2026,
author = {Li, Guoli and Zhang, Hongfang and Li, Lamei and Huang, Yun},
title = {Efficacy safety of linaclotide combined with polyethylene glycol for bowel preparation in patients with constipation: a meta-analysis},
journal = {Frontiers in Gastroenterology},
year = {2026},
volume = {5},
doi = {10.3389/fgstr.2026.1694950}
}
EUVIMED